Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Therapeutic implications of novel peptides targeting ER-mitochondria Ca2+-flux systems.

Kerkhofs M, Bultynck G, Vervliet T, Monaco G.

Drug Discov Today. 2019 May;24(5):1092-1103. doi: 10.1016/j.drudis.2019.03.020. Epub 2019 Mar 22. Review.

PMID:
30910738
2.

ABT-199 (Venetoclax), a BH3-mimetic Bcl-2 inhibitor, does not cause Ca2+ -signalling dysregulation or toxicity in pancreatic acinar cells.

Jakubowska MA, Kerkhofs M, Martines C, Efremov DG, Gerasimenko JV, Gerasimenko OV, Petersen OH, Bultynck G, Vervliet T, Ferdek PE.

Br J Pharmacol. 2018 Sep 28. doi: 10.1111/bph.14505. [Epub ahead of print]

PMID:
30266036
3.

Carbohydrate Loading to Combat Acute Pancreatitis.

Vervliet T, Yule DI, Bultynck G.

Trends Biochem Sci. 2018 Oct;43(10):741-744. doi: 10.1016/j.tibs.2018.08.001. Epub 2018 Aug 28.

PMID:
30170888
4.

Lnc'ing Ca2+, SERCA and cardiac disease.

Vervliet T, Robinson EL, Roderick HL.

Cell Calcium. 2018 Jun;72:132-134. doi: 10.1016/j.ceca.2018.05.005. Epub 2018 May 17.

PMID:
29793762
5.

BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis.

Vervliet T, Gerasimenko JV, Ferdek PE, Jakubowska MA, Petersen OH, Gerasimenko OV, Bultynck G.

Cell Death Discov. 2018 May 10;4:58. doi: 10.1038/s41420-018-0054-5. eCollection 2018.

6.

Ryanodine Receptors in Autophagy: Implications for Neurodegenerative Diseases?

Vervliet T.

Front Cell Neurosci. 2018 Mar 27;12:89. doi: 10.3389/fncel.2018.00089. eCollection 2018. Review.

7.

IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer.

Kania E, Roest G, Vervliet T, Parys JB, Bultynck G.

Front Oncol. 2017 Jul 5;7:140. doi: 10.3389/fonc.2017.00140. eCollection 2017. Review.

8.

DebULKing fat in the heart: a fascinating role for autophagy.

Vervliet T, Bultynck G.

Cardiovasc Res. 2017 Aug 1;113(10):1089-1092. doi: 10.1093/cvr/cvx127. No abstract available.

PMID:
28666348
9.

Modulation of Ca2+ Signaling by Anti-apoptotic B-Cell Lymphoma 2 Proteins at the Endoplasmic Reticulum-Mitochondrial Interface.

Vervliet T, Clerix E, Seitaj B, Ivanova H, Monaco G, Bultynck G.

Front Oncol. 2017 May 3;7:75. doi: 10.3389/fonc.2017.00075. eCollection 2017. Review.

10.

Basal ryanodine receptor activity suppresses autophagic flux.

Vervliet T, Pintelon I, Welkenhuyzen K, Bootman MD, Bannai H, Mikoshiba K, Martinet W, Nadif Kasri N, Parys JB, Bultynck G.

Biochem Pharmacol. 2017 May 15;132:133-142. doi: 10.1016/j.bcp.2017.03.011. Epub 2017 Mar 18.

PMID:
28322744
11.

The BH4 domain of Bcl-2 orthologues from different classes of vertebrates can act as an evolutionary conserved inhibitor of IP3 receptor channels.

Ivanova H, Luyten T, Decrock E, Vervliet T, Leybaert L, Parys JB, Bultynck G.

Cell Calcium. 2017 Mar;62:41-46. doi: 10.1016/j.ceca.2017.01.010. Epub 2017 Jan 25.

PMID:
28179071
12.

Bcl-2 proteins and calcium signaling: complexity beneath the surface.

Vervliet T, Parys JB, Bultynck G.

Oncogene. 2016 Sep 29;35(39):5079-92. doi: 10.1038/onc.2016.31. Epub 2016 Mar 14. Review.

PMID:
26973249
13.

Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein-protein interactions for channel regulation.

Vervliet T, Parys JB, Bultynck G.

Biochem Soc Trans. 2015 Jun;43(3):396-404. doi: 10.1042/BST20140298. Review.

PMID:
26009182
14.

Regulation of the ryanodine receptor by anti-apoptotic Bcl-2 is independent of its BH3-domain-binding properties.

Vervliet T, Lemmens I, Welkenhuyzen K, Tavernier J, Parys JB, Bultynck G.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):174-9. doi: 10.1016/j.bbrc.2015.04.131. Epub 2015 May 6.

PMID:
25957473
15.

Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain.

Vervliet T, Lemmens I, Vandermarliere E, Decrock E, Ivanova H, Monaco G, Sorrentino V, Nadif Kasri N, Missiaen L, Martens L, De Smedt H, Leybaert L, Parys JB, Tavernier J, Bultynck G.

Sci Rep. 2015 Apr 15;5:9641. doi: 10.1038/srep09641.

16.

Bcl-2 binds to and inhibits ryanodine receptors.

Vervliet T, Decrock E, Molgó J, Sorrentino V, Missiaen L, Leybaert L, De Smedt H, Kasri NN, Parys JB, Bultynck G.

J Cell Sci. 2014 Jun 15;127(Pt 12):2782-92. doi: 10.1242/jcs.150011. Epub 2014 Apr 24.

17.

Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.

Ivanova H, Vervliet T, Missiaen L, Parys JB, De Smedt H, Bultynck G.

Biochim Biophys Acta. 2014 Oct;1843(10):2164-83. doi: 10.1016/j.bbamcr.2014.03.007. Epub 2014 Mar 15. Review.

18.

IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2.

Akl H, Monaco G, La Rovere R, Welkenhuyzen K, Kiviluoto S, Vervliet T, Molgó J, Distelhorst CW, Missiaen L, Mikoshiba K, Parys JB, De Smedt H, Bultynck G.

Cell Death Dis. 2013 May 16;4:e632. doi: 10.1038/cddis.2013.140.

19.

Regulation of inositol 1,4,5-trisphosphate receptors during endoplasmic reticulum stress.

Kiviluoto S, Vervliet T, Ivanova H, Decuypere JP, De Smedt H, Missiaen L, Bultynck G, Parys JB.

Biochim Biophys Acta. 2013 Jul;1833(7):1612-24. doi: 10.1016/j.bbamcr.2013.01.026. Epub 2013 Feb 1. Review.

20.

The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond.

Monaco G, Vervliet T, Akl H, Bultynck G.

Cell Mol Life Sci. 2013 Apr;70(7):1171-83. doi: 10.1007/s00018-012-1118-y. Epub 2012 Sep 6. Review.

PMID:
22955373
21.

Bax inhibitor-1 is a novel IP₃ receptor-interacting and -sensitizing protein.

Kiviluoto S, Schneider L, Luyten T, Vervliet T, Missiaen L, De Smedt H, Parys JB, Methner A, Bultynck G.

Cell Death Dis. 2012 Aug 9;3:e367. doi: 10.1038/cddis.2012.103. No abstract available.

22.

Selective regulation of IP3-receptor-mediated Ca2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl.

Monaco G, Decrock E, Akl H, Ponsaerts R, Vervliet T, Luyten T, De Maeyer M, Missiaen L, Distelhorst CW, De Smedt H, Parys JB, Leybaert L, Bultynck G.

Cell Death Differ. 2012 Feb;19(2):295-309. doi: 10.1038/cdd.2011.97. Epub 2011 Aug 5.

Supplemental Content

Loading ...
Support Center